Kinnate Biopharma Inc. Annual Weighted Average Number of Shares Outstanding, Diluted from 2020 to 2023

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Kinnate Biopharma Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2020 to 2023.
  • Kinnate Biopharma Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2023 was 46.6M shares, a 5.7% increase year-over-year.
  • Kinnate Biopharma Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 46.6M shares, a 5.7% increase from 2022.
  • Kinnate Biopharma Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 44.1M shares, a 1.07% increase from 2021.
  • Kinnate Biopharma Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 43.6M shares, a 544% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 46.6M +2.51M +5.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 44.1M +465K +1.07% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 43.6M +36.8M +544% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-15
2020 6.77M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.